Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | CHIEF OPERATING OFFICER | February 08, 2024 | February 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date February 08, 2024 · Filed February 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 322,060 |
Ending reported balance
After 2024-02-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-02-08 · Exercise / conversion · Acquired 31,657 · Balance 335,859 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2024-02-08 · Tax withholding · Disposed 13,799 · Balance 322,060 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 411,538 |
Reported balance
After 2024-02-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-02-08 · Exercise / conversion · Disposed 31,657 · Balance 411,538 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2024 Filed Feb 8, 2024 21:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 31,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000015 · wk-form4_1707429517.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 411,538 Underlying: Class A Common Stock · 31,657 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 21:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 13,799 | $6.22 | $85,829.78 |
DisclosureSEC source: 0001809519-24-000015 · wk-form4_1707429517.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,060 Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 21:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 31,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000015 · wk-form4_1707429517.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,859 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 20, 2023 Filed Nov 20, 2023 22:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 91,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000039 · wk-form4_1700520444.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 910,255 Underlying: Class A Common Stock · 91,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The original grant of 1,456,408 restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The original grant of 1,456,408 restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 20, 2023 Filed Nov 20, 2023 22:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 50,338 | $5.23 | $263,267.74 |
DisclosureSEC source: 0001809519-23-000039 · wk-form4_1700520444.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,202 Read SEC document |
| November 20, 2023 Filed Nov 20, 2023 22:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000039 · wk-form4_1700520444.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 354,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 08, 2023 Filed Nov 8, 2023 21:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 31,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000027 · wk-form4_1699479805.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,195 Underlying: Class A Common Stock · 31,657 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 08, 2023 Filed Nov 8, 2023 21:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 17,507 | $5.40 | $94,537.80 |
DisclosureSEC source: 0001809519-23-000027 · wk-form4_1699479805.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,514 Read SEC document |
| November 08, 2023 Filed Nov 8, 2023 21:43 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 31,657 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000027 · wk-form4_1699479805.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 21:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 91,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000003 · wk-form4_1692738662.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,001,281 Underlying: Class A Common Stock · 91,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The original grant of 1,456,408 restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The original grant of 1,456,408 restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 21:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 50,337 | $6.72 | $338,264.64 |
DisclosureSEC source: 0001809519-23-000003 · wk-form4_1692738662.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,364 Read SEC document |
| August 20, 2023 Filed Aug 22, 2023 21:11 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000003 · wk-form4_1692738662.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 299,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 31,656 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-041298 · ownership.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 474,852 Underlying: Class A Common Stock · 31,656 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 17,506 | $8.68 | $151,952.08 |
DisclosureSEC source: 0000950170-23-041298 · ownership.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,676 Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:05 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 31,656 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-041298 · ownership.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock option (Right to Buy) · Derivative | 692,252 | $0.00 Strike: $5.53 | $0.00 |
DisclosureSEC source: 0000950170-23-025768 · ownership.xml · derivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 692,252 Underlying: Class A Common Stock · 692,252 shares Expires 2033-05-30 F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:58 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Units · Derivative | 506,508 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-025768 · ownership.xml · derivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 506,508 Underlying: Class A Common Stock · 506,508 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 20, 2023 Filed May 23, 2023 00:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 91,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-023518 · ownership.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,092,306 Underlying: Class A Common Stock · 91,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The original grant of 1,456,408 restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The original grant of 1,456,408 restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 20, 2023 Filed May 23, 2023 00:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 43,797 | $5.08 | $222,488.76 |
DisclosureSEC source: 0000950170-23-023518 · ownership.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,526 Read SEC document |
| May 20, 2023 Filed May 23, 2023 00:03 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-023518 · ownership.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 91,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005906 · doc4.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,183,332 Underlying: Class A Common Stock · 91,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 37,604 | $5.29 | $198,925.16 |
DisclosureSEC source: 0000899243-23-005906 · doc4.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,297 Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 01:49 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-005906 · doc4.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,901 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 20, 2022 Filed Nov 21, 2022 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 91,025 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-036514 · doc4.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,274,357 Underlying: Class A Common Stock · 91,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares have vested or will vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 20, 2022 Filed Nov 21, 2022 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 50,337 | $4.62 | $232,556.94 |
DisclosureSEC source: 0000899243-22-036514 · doc4.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,876 Read SEC document |
| November 20, 2022 Filed Nov 21, 2022 21:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,025 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-036514 · doc4.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 20, 2022 Filed Aug 23, 2022 20:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 91,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-029525 · doc4.xml · derivative · entry 3 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,365,382 Underlying: Class A Common Stock · 91,026 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares will vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares will vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 20, 2022 Filed Aug 23, 2022 20:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 37,838 | $6.00 | $227,028.00 |
DisclosureSEC source: 0000899243-22-029525 · doc4.xml · nonDerivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,188 Read SEC document |
| August 20, 2022 Filed Aug 23, 2022 20:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 91,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-029525 · doc4.xml · nonDerivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:17 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock option (Right to Buy) · Derivative | 1,788,419 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0000899243-22-023416 · doc4.xml · derivative · entry 2 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,788,419 Underlying: Class A Common Stock · 1,788,419 shares Expires 2032-06-16 F3 · derivative.exercise_date: The option will vest and become exercsiable as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:17 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Units · Derivative | 1,456,408 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-023416 · doc4.xml · derivative · entry 1 Beri Raj · CIK 0001927254 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,456,408 Underlying: Class A Common Stock · 1,456,408 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 20, 2022 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.